Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.
about
Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathyPredictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic ratsCurrent applications of biomarkers in cardiomyopathies.Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.Medico-legal perspectives on sudden cardiac death in young athletes.Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples.Current and future roles of biochemical biomarkers in hypertrophic cardiomyopathy.Fibrosis and coronary perfusion - a cardiovascular disease risk in an African male cohort: The SABPA study.Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.Oral sophocarpine protects rat heart against pressure overload-induced cardiac fibrosis.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy.Usefulness of Serum Omentin-1 Levels for the Predictions of Adverse Cardiac Events in Patients with Hypertrophic Cardiomyopathy.Cellular FLICE-like inhibitory protein protects against cardiac hypertrophy by blocking ASK1/p38 signaling in mice.Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic CardiomyopathyOccasionally increased F-fluorodeoxyglucose uptake in apical hypertrophic cardiomyopathy with mid-ventricular obstruction
P2860
Q33167509-1DE1E103-6970-436F-ABA2-D5CA9FE43658Q33855587-E50B218C-F188-40CE-8C73-66A2C097252FQ35893689-4B09800A-BB30-4C07-A75D-B0D111C73EDFQ36307139-A39BF8D6-0EA4-4BAD-A3FF-313385DC34C1Q38536678-B62A31D8-361A-42CA-A1DA-E6867975D847Q38906321-EE9C3D74-AABD-425F-BE01-7F42EF93687CQ38961073-917F4D3C-183E-411E-A578-716E39F73B1DQ39107858-A8AE0D53-3397-4279-9619-759D9A5EB793Q39198228-46921197-955E-4647-9D59-FFC226962EE6Q39297709-8FA5CC0D-B66A-44F9-B336-0FCAF6399105Q40666398-B42DA4BE-F8F7-4C2C-B9F2-71046B10E558Q41102423-3DC905A8-524B-43E2-9B13-857F28815C69Q42232319-CB4EA40D-0968-4FDA-90F2-1B8F511C98E6Q42515078-F89DA47C-2194-419A-99C8-5F1F2983857BQ47103526-9CE7532E-8E4F-4376-B534-CAD85743461EQ47152878-AD3A259F-B65B-4ECE-AAA2-7F1BAF3AB1F5Q47340487-DE5A8D4A-6396-45A1-8B10-4D7E01E3B168Q50198294-A50A1E0E-8796-4659-BB08-28B4A3A82C85Q55072312-A4E3CAE5-63D7-4182-B26F-B9F0D1B16410Q57115246-D19D6D86-7EC9-4258-B5D0-7B20A91D84CBQ57153590-6220B9E4-EF7F-4232-939B-8D49E3299858
P2860
Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@ast
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@en
type
label
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@ast
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@en
prefLabel
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@ast
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@en
P2093
P2860
P50
P1433
P1476
Low-grade inflammation and the ...... n hypertrophic cardiomyopathy.
@en
P2093
Anita Naukkarinen
Ivana Kholová
Kari Punnonen
Keijo Peuhkurinen
Pertti Jääskeläinen
Petri Sipola
Vesa Kärjä
P2860
P304
P356
10.1136/HEARTJNL-2011-300960
P407
P577
2012-03-24T00:00:00Z